Colgate-Palmolive Co. CL posted adjusted earnings of 75 cents a share in fourth-quarter 2017, in line with the Zacks Consensus Estimate and flat with the prior-year quarter. Including one-time items, earnings came in at 37 cents a share compared with 68 cents reported in the year-ago period.
Total sales of $3,892 million improved 4.5% from the year-ago period but lagged the Zacks Consensus Estimate of $3,916 million. The top line gained from 3% increase in global unit volumes and favorable currency impact of 2.5%, offset by 1% decline in pricing. Further, strong volume gains in Latin America, North America and Europe aided sales growth.
On an organic basis (excluding foreign exchange, acquisitions and divestitures), the company’s sales jumped 2%.
Colgate-Palmolive Company Price, Consensus and EPS Surprise
Colgate-Palmolive Company Price, Consensus and EPS Surprise | Colgate-Palmolive Company Quote
Following the earnings release, Colgate’s shares declined 3.6% in the pre-market trading hours. However, the stock has increased 9.8% in the last three months, outperforming the broader industry’s growth of 3.8%.
Deeper Insight
Adjusted gross profit margin of 60.4% contracted 40 basis points (bps) from the prior-year quarter driven by higher raw and packaging material expenses and lower pricing. However, this was partially offset by gains from the cost-saving initiatives under the company’s funding-the-growth program.
In the reported quarter, adjusted operating profit of $1,011 million dipped 3%, with the adjusted operating margin contracting 190 basis points (bps) to 26%. Operating margin decline can be attributed to 160 bps rise in adjusted selling, general & administrative expenses as a percentage of sales, which included higher investments in advertising.
Year to date, Colgate’s market share of manual toothbrushes has reached 32.6%. Further, the company continued with its leadership in the global toothpaste market with 43.3% market share year to date.
Segment Discussion
North America net sales (21% of total sales) rose 1%, reflecting a 4.5% increase in unit volumes offset by 3.5% fall in pricing. However, currency impacts were flat with last year. On an organic basis too, sales improved 1%.
Latin America net sales (25% of total sales) jumped 4% year over year gaining from 4% volume gains and positive currency impact of 1.5%, partly negated by 1.5% decline in pricing. Volume growth can mainly be attributed to increase in Brazil and the Southern Cone and Andean regions, partially mitigated by lower volumes in Mexico and Central America. On an organic basis, sales increased 2.5%.
Europe net sales (16% of total sales) rose 13% year over year, due to 6% increase in unit volumes and a favorable currency impact of 9%, offset by 2% decline in pricing. Unit volumes gained from strength in France, Italy and Germany. Europe organic sales were up 4%.
Asia Pacific net sales (17% of total sales) rose 6%, attributable to 1% increase in unit volume, 1.5% higher pricing and positive currency impacts of 3.5%. Volumes in the quarter benefited from strength in India, which was partly neutralized by declines in the Greater China and the Philippines regions. On an organic basis, sales for Asia Pacific were up 2.5%.
Africa/Eurasia net sales (6% of total sales) jumped 2% year over year, fueled by 2.5% gains from positive currency, partly offset by 0.5% drop in unit volumes while pricing was flat. Lower volumes in the Sub-Turkey and the North Africa/Middle East regions, were partly offset by gains in Russia and the Sub-Saharan Africa region. Organic sales for Africa/Eurasia dropped 0.5%.
Hill’s Pet Nutrition net sales (15% of total sales) were up 2.5% from the year-ago quarter. Results gained from 0.5% increase in pricing and 2% positive impact from currency, while unit volumes remained flat. Volume gains in the United States and Australia were offset by fall in Japan, France and South Africa. On an organic basis, sales rose 0.5%.
Other Financial Details
Colgate ended the year with cash and cash equivalents of $1,535 million and total debt of $6,577 million. Net cash provided by operating activities came in at $3,054 million 2017.
Outlook
Looking into 2018, Colgate anticipates the backdrop to remain challenging due to uncertain global markets and slowing category growth worldwide. However, the company remains on track with its brand building and productivity maximization initiatives. Consequently, the company expects net sales to increase in the mid-single-digit range, while organic sales growth of low to mid-single-digit is likely in 2018.
Including the impact of the expanded Global Growth and Efficiency Program, the company continues to expect gross margin expansion for 2018, along with double digits increase in GAAP earnings per share.
Excluding the restructuring charges resulting from the program and other one-time expenses associated with U.S. tax reform in 2017, the company projects strong cash flow generation, gross margin expansion and higher advertising investments in 2018. Further, the company anticipates low double-digit earnings per share growth for the year, on an adjusted basis.
Accounting for the U.S. tax reform, the company anticipates 2018 tax of 26%-27%, both on a GAAP basis and excluding the impact of the Global Growth and Efficiency Program.
Zacks Rank & Key Picks
Colgate currently carries a Zacks Rank #3 (Hold). Better-ranked stocks in the consumer staples sector include The Boston Beer Co. Inc. SAM, Brown-Forman Corp. BF.B and Service Corporation International SCI, all carrying a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Boston Beer, with long-term EPS growth rate of 5%, has increased 11.2% in the last three months.
Brown-Forman has increased 22.9% in the last three months. Moreover, the company has to its credit a spectacular earnings history as it delivered an average positive earnings surprise of nearly 7% in the trailing four quarters.
Service Corporation, with long-term EPS growth rate of 11.6%, has grown 12.1% in last three months.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment